iminodiacetic acid disodium salt hydrate | CAS:17593-73-6

We serve iminodiacetic acid disodium salt hydrate CAS:17593-73-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
iminodiacetic acid disodium salt hydrate

CAS No: 17593-73-6
Product Name: iminodiacetic acid disodium salt hydrate
Other Name:
iminodiacetic acid disodium salt hydrate
SodiuM iMinodiacetate Monohydrate
Iminodiacetic acid sodium salt
 
Density: 1.436g/cm3
Boiling Point: 370.6ºC at 760mmHg
Melting Point: 180 °C
Molecular Formula: C4H7NNa2O5
Molecular Weight: 195.08200
Flash Point: 177.9ºC
Exact Mass: 195.01200
PSA: 101.52000
 
Specification
Appearance: Yellow crystalline powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Glyphosate CAS: 1071-83-6.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Glyphosate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like iminodiacetic acid disodium salt hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Iminodiacetic acid sodium salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,iminodiacetic acid disodium salt hydrate Use and application,SodiuM iMinodiacetate Monohydrate technical grade,usp/ep/jp grade.


Related News: He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines.BABPA-B manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.1,3-dimethylbarbituric acid supplier Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.2,5-Dibromo-4-methylpyridine vendor